123 related articles for article (PubMed ID: 29356745)
1. Virchow Node From Prostate Carcinoma by 18F-Choline PET/CT.
de la Riva-Pérez PA; García-Gómez FJ; Buján-Lloret C; Calvo-Morón MC; Castro-Montaño J
Clin Nucl Med; 2018 Apr; 43(4):271-272. PubMed ID: 29356745
[TBL] [Abstract][Full Text] [Related]
2. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
Vadrucci M; Gilardi L; Grana CM
Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
[TBL] [Abstract][Full Text] [Related]
4. Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
Pinaquy JB; Allard JB; Cornelis F; Pasticier G; De Clermont H
Clin Nucl Med; 2015 Apr; 40(4):e255-7. PubMed ID: 25674860
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
Fodor A; Berardi G; Fiorino C; Picchio M; Busnardo E; Kirienko M; Incerti E; Dell'Oca I; Cozzarini C; Mangili P; Pasetti M; Calandrino R; Gianolli L; Di Muzio NG
BJU Int; 2017 Mar; 119(3):406-413. PubMed ID: 27104782
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of CT-Guided Percutaneous Biopsy of Suspicious Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Detected by
Kapplinger JD; Lima LMF; Packard AT; Nathan MA; Young JR; Stish BJ; Hough DM
AJR Am J Roentgenol; 2023 May; 220(5):718-725. PubMed ID: 36475814
[No Abstract] [Full Text] [Related]
7. Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
Van den Broeck B; De Maeseneer D; De Gersem R; De Man K
Clin Nucl Med; 2017 Apr; 42(4):e207-e209. PubMed ID: 28134691
[TBL] [Abstract][Full Text] [Related]
8. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
[TBL] [Abstract][Full Text] [Related]
9. Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml.
Evangelista L; Cuppari L; Guttilla A; Gardi M; Agostini A; Ruggera L; Basso U; Saladini G
Nucl Med Commun; 2018 Mar; 39(3):260-267. PubMed ID: 29381584
[TBL] [Abstract][Full Text] [Related]
10. 11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
Mapelli P; Incerti E; Ceci F; Castellucci P; Fanti S; Picchio M
J Nucl Med; 2016 Oct; 57(Suppl 3):43S-48S. PubMed ID: 27694171
[TBL] [Abstract][Full Text] [Related]
11. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
[TBL] [Abstract][Full Text] [Related]
12. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
13. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
[TBL] [Abstract][Full Text] [Related]
15. Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
Evangelista L; Guttilla A; Zattoni F; Muzzio PC; Zattoni F
Eur Urol; 2013 Jun; 63(6):1040-8. PubMed ID: 23036576
[TBL] [Abstract][Full Text] [Related]
16. Incidental Finding of Intrathyroid Metastases of Prostatic Cancer on 18F-Choline PET/CT.
Vija Racaru L; Gabiache E; Fontaine S; DʼAure D; Mourey L; Courbon F; Zerdoud S
Clin Nucl Med; 2019 Feb; 44(2):e101-e103. PubMed ID: 30516690
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Nanni C; Zanoni L; Pultrone C; Schiavina R; Brunocilla E; Lodi F; Malizia C; Ferrari M; Rigatti P; Fonti C; Martorana G; Fanti S
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1601-10. PubMed ID: 26960562
[TBL] [Abstract][Full Text] [Related]
18.
Cardona Arboniés J; Rodríguez Alfonso B; Mucientes Rasilla J; Martínez Ballesteros C; Zapata Paz I; Prieto Soriano A; Carballido Rodriguez J; Mitjavila Casanovas M
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):292-297. PubMed ID: 28366421
[TBL] [Abstract][Full Text] [Related]
19. 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer.
Witkowska-Patena E; Giżewska A; Miśko J; Dziuk M
Clin Nucl Med; 2019 Jun; 44(6):e401-e403. PubMed ID: 30932984
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.
Ceci F; Castellucci P; Mapelli P; Incerti E; Picchio M; Fanti S
J Nucl Med; 2016 Oct; 57(Suppl 3):49S-54S. PubMed ID: 27694172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]